X-154712306-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001081573.3(GAB3):c.992G>A(p.Gly331Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,209,116 control chromosomes in the GnomAD database, including 1 homozygotes. There are 49 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001081573.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAB3 | ENST00000424127.3 | c.992G>A | p.Gly331Asp | missense_variant | 4/10 | 1 | NM_001081573.3 | ENSP00000399588.2 | ||
GAB3 | ENST00000369575.7 | c.989G>A | p.Gly330Asp | missense_variant | 4/10 | 1 | ENSP00000358588.3 | |||
GAB3 | ENST00000496390.5 | n.616+901G>A | intron_variant | 1 | ||||||
GAB3 | ENST00000369568.8 | c.992G>A | p.Gly331Asp | missense_variant | 4/9 | 2 | ENSP00000358581.4 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 111843Hom.: 0 Cov.: 23 AF XY: 0.0000588 AC XY: 2AN XY: 33991
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 181910Hom.: 0 AF XY: 0.0000151 AC XY: 1AN XY: 66434
GnomAD4 exome AF: 0.000137 AC: 150AN: 1097219Hom.: 1 Cov.: 30 AF XY: 0.000130 AC XY: 47AN XY: 362609
GnomAD4 genome AF: 0.0000268 AC: 3AN: 111897Hom.: 0 Cov.: 23 AF XY: 0.0000587 AC XY: 2AN XY: 34055
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2024 | The c.992G>A (p.G331D) alteration is located in exon 4 (coding exon 4) of the GAB3 gene. This alteration results from a G to A substitution at nucleotide position 992, causing the glycine (G) at amino acid position 331 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at